2 year use of Aflibercept study for treatment of wet AMD

• Research type

  Research Study

• Full title

  A prospective, observational, multi centre, 2 year study evaluating the use of aflibercept (Eylea) for the treatment of neovascular (wet) age related macular degeneration in UK NHS opthalmology clinics.

• IRAS ID

  136457

• Contact name

  Fosca De Iorio

• Contact email

  fosca.de_iorio@novartis.com

• Sponsor organisation

  Novartis

• REC name

  East of England - Cambridge South Research Ethics Committee

• REC reference

  13/EE/0274

• Date of REC Opinion

  9 Aug 2013

• REC opinion

  Favourable Opinion